Status:
RECRUITING
Cognitive Impairment in Ageing People
Lead Sponsor:
Yamei Tang
Conditions:
MCI
Alzheimer Disease
Eligibility:
All Genders
50+ years
Brief Summary
Mild cognitive impairment (MCI) and neurocognitive disorder such as Alzheimer's disease (AD) and Vascular dementia (VaD) have become common diseases in the elderly. The burden of dementia is rising in...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients over 50 years old.
- Sign informed consent.
- According to DSM-IV, the diagnostic standard of dementia was not met.
- The clinical dementia rating (CDR) was 0.5.
- Exclusion criteria:
- Subjects with mental retardation.
- Refuse to have blood sampling, imaging and other examinations.
- Uncooperative subjects that have serious organic diseases, or have a history of mental illness, or have physical disability (including severe aphasia).
- Contraindications of MR scanning.
- Suffering from serious physical or mental illness.
Exclusion
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2040
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04360200
Start Date
April 1 2020
End Date
December 1 2040
Last Update
September 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China, 510120